Latest Breaking News On - சிவப்பு நிறுவனம் ஆஃப் வாழ்க்கை அறிவியல் - Page 1 : comparemela.com

New drug combination could improve glucose, weight control

New drug combination could improve glucose, weight control
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United statesShilpak belePrasenjit mitraReddy institute of life sciencesஒன்றுபட்டது மாநிலங்களில்பிரசேஞ்சித் மித்ராசிவப்பு நிறுவனம் ஆஃப் வாழ்க்கை அறிவியல்

New drug combination improves blood glucose control and weight loss in mice

New drug combination improves blood glucose control and weight loss in mice Scientists have shown that adding an experimental cancer drug to a widely used diabetes treatment improves blood glucose control and weight loss in mice, according to a study published today in eLife. The results pave the way for clinical studies of the new drug combination as a more effective long-term treatment for millions of people with diabetes and obesity. Glucagon-like peptide 1 agonists (GLP-1 analogs) are a relatively new class of drugs that reduce blood sugar levels and lower body weight. They partially function by binding to the glucagon-like peptide 1 receptor on pancreatic beta cells, which leads the cells to produce insulin. But not all patients achieve normalization of blood glucose control with GLP-1 drugs, and very few achieve full reversal of obesity.

Shilpak belePrasenjit mitraEmily hendersonReddy institute of life sciencesTeam leaderProject team leaderபிரசேஞ்சித் மித்ராஎமிலி ஹென்டர்சன்சிவப்பு நிறுவனம் ஆஃப் வாழ்க்கை அறிவியல்அணி தலைவர்ப்ராஜெக்ட் அணி தலைவர்

New drug combination could improve glucose, weight control in diabetes

New drug combination could improve glucose, weight control in diabetes ANI | Updated: Dec 23, 2020 16:56 IST Washington [US], December 23 (ANI): Scientists have shown that adding an experimental cancer drug to a widely used diabetes treatment improves blood glucose control and weight loss in mice, according to a study. The study was published in the journal eLife. The results pave the way for clinical studies of the new drug combination as a more effective long-term treatment for millions of people with diabetes and obesity. Glucagon-like peptide 1 agonists (GLP-1 analogs) are a relatively new class of drugs that reduce blood sugar levels and lower body weight. They partially function by binding to the glucagon-like peptide 1 receptor on pancreatic beta cells, which leads the cells to produce insulin. But not all patients achieve normalisation of blood glucose control with GLP-1 drugs, and very few achieve a full reversal of obesity.

United statesShilpak belePrasenjit mitraReddy institute of life sciencesஒன்றுபட்டது மாநிலங்களில்பிரசேஞ்சித் மித்ராசிவப்பு நிறுவனம் ஆஃப் வாழ்க்கை அறிவியல்

New drug combination could improve glucose and weight control in diabetes

E-Mail Scientists have shown that adding an experimental cancer drug to a widely used diabetes treatment improves blood glucose control and weight loss in mice, according to a study published today in eLife. The results pave the way for clinical studies of the new drug combination as a more effective long-term treatment for millions of people with diabetes and obesity. Glucagon-like peptide 1 agonists (GLP-1 analogs) are a relatively new class of drugs that reduce blood sugar levels and lower body weight. They partially function by binding to the glucagon-like peptide 1 receptor on pancreatic beta cells, which leads the cells to produce insulin. But not all patients achieve normalisation of blood glucose control with GLP-1 drugs, and very few achieve full reversal of obesity.

Emily packerPrasenjit mitraShilpak beleReddy institute of life sciencesAlice wallenberg foundationMax planck societyHoward hughes medical instituteMedia relations managerCell biologyஎமிலி ப்யாகர்பிரசேஞ்சித் மித்ராசிவப்பு நிறுவனம் ஆஃப் வாழ்க்கை அறிவியல்ஆலிஸ் வாலன்பெர்க் அடித்தளம்ஹோவர்ட் ஹக்ஸ் மருத்துவ நிறுவனம்மீடியா உறவுகள் மேலாளர்செல் உயிரியல்